ArticleClinical and experimental hepatology2024

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease.

Yu-Ming Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.